Spike CD4+ and CD8+ T Cell Epitope Kits
To accommodate the need for rapid vaccine development and to understand patient immune responses, Immunitrack offers two Spike T cell epitope kits, which may be used to stimulate antigen-specific T cells in assays such as ELISpot, intracellular cytokine staining assays, and cytotoxicity or proliferation assays.
These products are the result of a collaboration between Intavis and Immunitrack and may be ordered by contacting Immunitrack.
Each kit consists of 96 SARS-CoV-2 Spike peptides validated in in vitro stability binding assays to one or more frequent HLA alleles. The kit comes with a report containing the binding assay data.